• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVEDERM VOLUMA WITH LIDOCAINE 1 ML; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVEDERM VOLUMA WITH LIDOCAINE 1 ML; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 94506KO
Device Problems Break (1069); Shelf Life Exceeded (1567)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/09/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Device history record summary: the release step combined with the absence of any deviation shows that no element could explain these issues: all the syringes are inspected individually after filling and no problem was detected.There were no non conformities with the different elements of the syringes (syringe, plunger, plunger rod, tip cap, finger grip).Device labeling for the reported event: "method of use: this product is to be used as supplied.Modification or use of the product outside the directions for use may adversely impact the sterility, homogeneity and performance of the product and it can therefore no longer be assured.Warnings: check the expiry date on the product label.[expiration date] refer to the use by date ( ) on the label at the side of the product packing box".
 
Event Description
Healthcare professional reported injecting a patient with juvéderm® voluma® with lidocaine in the forehead using the packaged needle.The syringe was "broken at luer lock" while changing the needle.The use of the device was approximately 2 years after the expiration date.There were no reported injuries.
 
Manufacturer Narrative
Device analysis: the 3mm luer lock is broken and a small part of plastic is missing.
 
Event Description
Healthcare professional reported injecting a patient with juvéderm® voluma® with lidocaine in the forehead using the packaged needle.The syringe was "broken at luer lock" while changing the needle.The use of the device was approximately 2 years after the expiration date.There were no reported injuries.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLUMA WITH LIDOCAINE 1 ML
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR   74370
Manufacturer Contact
suzanne wojcik
301 w howard lane
suite 100
austin, TX 78753
7372473605
MDR Report Key6461590
MDR Text Key71768382
Report Number3005113652-2017-00205
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/15/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/05/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2015
Device Catalogue Number94506KO
Device Lot NumberVB20A30210
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/09/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/11/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/13/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age36 YR
-
-